Factor VII Deficiency, Masked by Warfarin Therapy, as a Cause of Bleeding After Cardiovascular Intervention

[1]  G. Mariani,et al.  Invasive procedures and minor surgery in factor VII deficiency , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

[2]  John Camm,et al.  Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[3]  M. Karimi,et al.  Use of Glubran 2 and Glubran tissue skin adhesive in patients with hereditary bleeding disorders undergoing circumcision and dental extraction , 2011, Annals of Hematology.

[4]  D. Benditt,et al.  Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation. , 2010, Heart rhythm.

[5]  J. Healey,et al.  Postoperative Low‐Molecular‐Weight Heparin Bridging Is Associated with an Increase in Wound Hematoma Following Surgery for Pacemakers and Implantable Defibrillators , 2009, Pacing and clinical electrophysiology : PACE.

[6]  G. Simonetti,et al.  Transcatheter Embolization of a Large Symptomatic Pelvic Arteriovenous Malformation with Glubran 2 Acrylic Glue , 2008, CardioVascular and Interventional Radiology.

[7]  A. Viswabandya,et al.  Molecular basis of hereditary factor VII deficiency in India: five novel mutations including a double missense mutation (Ala191Glu; Trp364Cys) in 11 unrelated patients. , 2007, Haematologica.

[8]  C. Legnani,et al.  Warfarin Withdrawal , 1996, Clinical pharmacokinetics.

[9]  G. Raskob,et al.  Effect of treatment with low-dose warfarin-aspirin on activated factor VII. , 1995, Blood.

[10]  K. Kario,et al.  Suppression of plasma-activated factor VII levels by warfarin therapy. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[11]  B. Alexander.  Clotting factor VII (proconvertin): synonymy, properties, clinical and clinicolaboratory aspects. , 1959, The New England journal of medicine.